Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2001 1
2002 1
2004 4
2005 2
2006 2
2007 1
2008 2
2009 6
2010 4
2011 4
2012 3
2013 6
2014 10
2015 11
2016 8
2017 8
2018 12
2019 23
2020 29
2021 30
2022 45
2023 33
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for human saadati
Your search for Heman Saadati retrieved no results
Association between human herpesviruses and multiple sclerosis: A systematic review and meta-analysis.
Khalesi Z, Tamrchi V, Razizadeh MH, Letafati A, Moradi P, Habibi A, Habibi N, Heidari J, Noori M, Nahid Samiei M, Azarash Z, Hoseini M, Saadati H, Bahavar A, Farajzade M, Saeb S, Hadadi M, Sorouri Majd M, Mothlaghzadeh S, Fazli P, Asgari K, Kiani SJ, Ghorbani S. Khalesi Z, et al. Microb Pathog. 2023 Apr;177:106031. doi: 10.1016/j.micpath.2023.106031. Epub 2023 Feb 10. Microb Pathog. 2023. PMID: 36775211 Review.
In subgroup analysis, the pooled prevalence of Herpes simplex virus (HSV), Varicella-zoster virus (VZV), Epstein-Barr virus (EBV), Cytomegalovirus (CMV), Human herpes virus 6 (HHV-6), Human herpes virus 7 (HHV-7), and Human herpes virus 8 (HHV-8) was 32%, 52% …
In subgroup analysis, the pooled prevalence of Herpes simplex virus (HSV), Varicella-zoster virus (VZV), Epstein-Barr virus (EBV), Cytomegal …
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.
Döhner H, Weber D, Krzykalla J, Fiedler W, Wulf G, Salih H, Lübbert M, Kühn MWM, Schroeder T, Salwender H, Götze K, Westermann J, Fransecky L, Mayer K, Hertenstein B, Ringhoffer M, Tischler HJ, Machherndl-Spandl S, Schrade A, Paschka P, Gaidzik VI, Theis F, Thol F, Heuser M, Schlenk RF, Bullinger L, Saadati M, Benner A, Larson R, Stone R, Döhner K, Ganser A. Döhner H, et al. Blood Adv. 2022 Sep 27;6(18):5345-5355. doi: 10.1182/bloodadvances.2022007223. Blood Adv. 2022. PMID: 35486475 Free PMC article. Clinical Trial.
Marginal variable screening for survival endpoints.
Edelmann D, Hummel M, Hielscher T, Saadati M, Benner A. Edelmann D, et al. Biom J. 2020 May;62(3):610-626. doi: 10.1002/bimj.201800269. Epub 2019 Aug 26. Biom J. 2020. PMID: 31448463 Review.
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Döhner H, Weber D, Krzykalla J, Fiedler W, Kühn MWM, Schroeder T, Mayer K, Lübbert M, Wattad M, Götze K, Fransecky L, Koller E, Wulf G, Schleicher J, Ringhoffer M, Greil R, Hertenstein B, Krauter J, Martens UM, Nachbaur D, Samra MA, Machherndl-Spandl S, Basara N, Leis C, Schrade A, Kapp-Schwoerer S, Cocciardi S, Bullinger L, Thol F, Heuser M, Paschka P, Gaidzik VI, Saadati M, Benner A, Schlenk RF, Döhner K, Ganser A; German–Austrian AML Study Group. Döhner H, et al. Lancet Haematol. 2023 Jul;10(7):e495-e509. doi: 10.1016/S2352-3026(23)00089-3. Epub 2023 May 12. Lancet Haematol. 2023. PMID: 37187198 Clinical Trial.
Association between human polyomavirus infection and brain cancer: A systematic review and meta-analysis.
Goudarzi Far F, Tambrchi V, Nahid Samiei R, Nahid Samiei M, Saadati H, Moradi P, Keyvanlou Z, Advay S, Nili M, Abdi S, Jamalvandi T, Arash Letafati, Behzadpour M, Kamalpour M, Ebrahimdamavandi N, Khatami A, Kiani SJ, Ghorbani S. Goudarzi Far F, et al. Microb Pathog. 2022 Dec;173(Pt A):105797. doi: 10.1016/j.micpath.2022.105797. Epub 2022 Sep 29. Microb Pathog. 2022. PMID: 36183958 Review.
Thrombolytic Agents: Nanocarriers in Controlled Release.
Hassanpour S, Kim HJ, Saadati A, Tebon P, Xue C, van den Dolder FW, Thakor J, Baradaran B, Mosafer J, Baghbanzadeh A, de Barros NR, Hashemzaei M, Lee KJ, Lee J, Zhang S, Sun W, Cho HJ, Ahadian S, Ashammakhi N, Dokmeci MR, Mokhtarzadeh A, Khademhosseini A. Hassanpour S, et al. Small. 2020 Oct;16(40):e2001647. doi: 10.1002/smll.202001647. Epub 2020 Aug 12. Small. 2020. PMID: 32790000 Free PMC article. Review.
220 results